stockrowStandard BioTools Inc. (LAB) vs Treace Medical Concepts, Inc. (TMCI)
- Standard BioTools Inc. LAB 0.62 0.00%
- Treace Medical Concepts, Inc. TMCI 4.05 −3.11%
Standard BioTools Inc. and Treace Medical Concepts, Inc. are both Medical Devices companies. Treace Medical Concepts, Inc. is the larger, with a market value of $271.9M against $245.7M — 1.1× the size. Treace Medical Concepts, Inc. has negative trailing earnings, so its P/E is not meaningful; Standard BioTools Inc. trades at 1.8×. Standard BioTools Inc. grew revenue faster over the last twelve months: 35.3% against −3.95%. Standard BioTools Inc. has the higher net margin (157.6% vs −29.0%) and the lower return on invested capital (−54.2% vs −43.0%). Across the 18 metrics below, Standard BioTools Inc. leads on 10 and Treace Medical Concepts, Inc. on 8.
Valuation
Profitability
| Metric | LAB | TMCI | Medical Devices median |
|---|---|---|---|
| Gross margin | 52.18% | 79.45% | 57.76% |
| Operating margin | (97.47%) | (26.17%) | (15.07%) |
| Net margin | 157.62% | (28.99%) | (14.45%) |
| Free cash flow margin | (77.76%) | (12.20%) | (3.88%) |
| Return on equity | 27.86% | (71.99%) | (10.35%) |
| Return on assets | 22.65% | (30.72%) | (17.26%) |
| Return on invested capital | (54.18%) | (42.96%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack